Deucravacitinib vs Empagliflozin

## Deucravacitinib vs Empagliflozin: Overview

This comparison examines the pharmacological differences between **Deucravacitinib** and **Empagliflozin**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Deucravacitinib — N/A; Empagliflozin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Deucravacitinib — N/A; Empagliflozin — C23H27ClO7.

**Molecular Weight**: Deucravacitinib — N/A; Empagliflozin — 450.9100 g/mol.

**Type**: Deucravacitinib — Small molecule; Empagliflozin — Small molecule.